Aydın GENÇ

Dr. Aydın GENÇ

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2020 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
PDF file
MIMustafa Ileriturk
Mustafa Ileriturk
FBFulya Benzer
Fulya Benzer
EAEmrah Hicazi Aksu
Emrah Hicazi Aksu
SYSerkan YILDIRIM
Serkan YILDIRIM
FKFatih Mehmet Kandemir
Fatih Mehmet Kandemir
AGAydın GENÇ
Aydın GENÇ

7 June 2022 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
HSHalil S. Semis
Halil S. Semis
FKFatih M. Kandemir
Fatih M. Kandemir
CCCuneyt Caglayan
Cuneyt Caglayan
OKOzgur Kaynar
Ozgur Kaynar
AGAydın GENÇ
Aydın GENÇ
SASefik M. Arıkan
Sefik M. Arıkan


30 December 2020 in Türk Doğa ve Fen Dergisi
Verified
Journal Article
Open access
PDF file
CGCihan Gür
Cihan Gür
FKFatih Kandemi̇r
Fatih Kandemi̇r
AGAydın GENÇ
Aydın GENÇ
Bortezomib (BTZ), proteazom sistemini bloke ederek hücresel protein yıkımını engelleyen yeni nesil bir antineoplastik ilaçtır. Bu çalışmada BTZ kaynaklı kalp hasarına karşı bir izokinolin alkaloid olan berberinin (BBR) koruyucu etkileri araştırılmıştır. Çalışmada erkek Sprague Dawley cinsi ratlara 1., 3., 5. ve 7. günlerde periton içi 0,2 mg kg-1 BTZ ve 10 gün boyunca her gün 50 ve 100 mg kg-1 dozlarda BBR verildi. Ratların kalp dokularında malondialdehit (MDA), glutatyon (GSH), total antioksidan kapasite (TAK), total oksidan kapasite (TOK) ve nitrik oksit (NO) seviyeleri ile süperoksit dismutaz (SOD), katalaz (KAT), glutatyon peroksidaz (GPx) ve laktat dehidrogenaz (LDH) aktiviteleri biyokimyasal yöntemler ile analiz edildi. Veriler BTZ’nin kalp dokusunda MDA, NO ve TOK seviyelerini, serumda LDH aktivelerini ve oksidatif stres indeksini (OSI) önemli ölçüde arttırdığını, GSH ve TAK seviyeleri ile SOD, KAT ve GPx aktivitelerini azaltarak oksidatif stresi tetiklediğini buna bağlı olarak dokuda hasar oluşturduğunu gösterdi. Buna karşın BBR, BTZ’nin neden olduğu oksidatif stresi ve nitrozatif stresi hafifleterek kalp hasarına karşı koruyucu etki gösterdi. Sonuçlara göre BBR’nin, BTZ ile indüklenen kardiyak toksisiteye karşı daha ileri çalışmalardan sonra koruyucu olarak kullanılabileceğini gösterdi.

27 August 2025 in Bratislava Medical Journal
Verified
Journal Article
Closed access
PDF file
SKSefa Küçükler
Sefa Küçükler
SÇSelim ÇOMAKLI
Selim ÇOMAKLI
SÖSelçuk Özdemir
Selçuk Özdemir
ŞDŞükrü Değirmençay
Şükrü Değirmençay
FKFatih Mehmet Kandemir
Fatih Mehmet Kandemir
SASeyma AYDIN
Seyma AYDIN

6 April 2026 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Open access
AGAydın GENÇ
Aydın GENÇ
ESEmre Sahin
Emre Sahin
ECEren Cankaya
Eren Cankaya
Methotrexate (MTX) is a medication that is frequently prescribed for the treatment of both malignant disorders and inflammatory pathologies. However, its use is limited by dose‐dependent pulmonary toxicity. The present study investigated the protective effects of silymarin (SLM) against MTX‐induced lung injury by evaluating apoptosis, oxidative stress, autophagy, inflammation and histopathological changes in rats. Twenty‐eight Wistar albino rats were assigned to the Control, SLM (50 mg/kg, p. o.), MTX (20 mg/kg, i. p.), and MTX + SLM groups. MTX treatment led to a significant elevation in malondialdehyde levels along with marked reductions in glutathione content and antioxidant enzyme activities, concomitant with decreased Nrf2 and HO‐1 expression, indicating pronounced oxidative stress ( p < 0.05). Additionally, MTX has been shown to raise Bax and Caspase‐3 and diminish Bcl‐2 while simultaneously inducing NF‐κB, TNF‐α, TLR‐4, and HMGB1. This confirms the presence of increased inflammation and mitochondrial‐dependent apoptosis ( p < 0.05). Furthermore, MTX elevated the expression of LC3A, LC3B, and Beclin‐1, suggesting an increase in autophagy ( p < 0.05). SLM supplementation greatly improved antioxidant status, increased Nrf2/HO‐1, decreased inflammatory signaling, modulated Caspase‐3/Bax/Bcl‐2 expression, and suppressed MTX‐induced autophagy ( p < 0.05). These biochemical findings were subsequently corroborated by histopathological analysis. In summary, the present study demonstrates that SLM offers a promising protective effect against MTX‐induced pulmonary damage, operating through mechanisms involving antioxidant, anti‐autophagic, anti‐inflammatory and anti‐apoptotic actions. These results underscore the potential of SLM as a complementary therapeutic agent in mitigating lung toxicity induced by chemotherapy agents.